N-myc gene amplification/expression in localized stroma-rich neuroblastoma (ganglioneuroblastoma).

[1]  J. Bourhis,et al.  N-myc genomic content and DNA ploidy in stage IVS neuroblastoma. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  C. Dominici,et al.  Age-dependent prognostic significance of N-myc amplification in neuroblastoma. The Italian experience. , 1991, Cancer genetics and cytogenetics.

[3]  A T Look,et al.  Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  P. Nisen,et al.  N‐myc oncogene expression and amplification in metastatic lesions of stage IV‐S neuroblastoma , 1990, Cancer.

[5]  H. Takano,et al.  Inverse correlation between expression of multidrug resistance gene and N-myc oncogene in human neuroblastomas. , 1990, Cancer research.

[6]  T. Sasazuki,et al.  N‐myc oncogene and stage iv‐s neuroblastoma preliminary observations on ten cases , 1990, Cancer.

[7]  B. Korf,et al.  myc gene amplification and expression in primary human neuroblastoma. , 1990, Cancer research.

[8]  V. Combaret,et al.  Clinical value of N-myc oncogene amplification in 52 patients with neuroblastoma included in recent therapeutic protocols. , 1989, European journal of cancer & clinical oncology.

[9]  T. Jahnsen,et al.  N-myc amplification in neuroblastomas: histopathological, DNA ploidy, and clinical variables. , 1989, Journal of clinical pathology.

[10]  Y. Hayashi,et al.  Similar chromosomal patterns and lack of N-myc gene amplification in localized and IV-S stage neuroblastomas in infants. , 1989, Medical and pediatric oncology.

[11]  P. Waber,et al.  N-myc oncogene RNA expression in neuroblastoma. , 1988, Journal of the National Cancer Institute.

[12]  S. Hirohashi,et al.  Detection of amplified N-myc gene in neuroblastoma by in situ hybridization using the single-step silver enhancement method. , 1988, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[13]  K. Matthay,et al.  Complete pathologic maturation and regression of stage ivs neuroblastoma without treatment , 1988, Cancer.

[14]  M. Israel,et al.  Detection of N-myc gene expression in neuroblastoma tumors by in situ hybridization. , 1988, The American journal of pathology.

[15]  F. Lampert,et al.  Tumour karyotype discriminates between good and bad prognostic outcome in neuroblastoma. , 1988, British Journal of Cancer.

[16]  M. Carli,et al.  Localized neuroblastoma. Surgical and pathologic staging , 1987, Cancer.

[17]  A. Nakagawara,et al.  Analysis of N‐myc amplification in relation to disease stage and histologic types in human neuroblastomas , 1987, Cancer.

[18]  J. Wasson,et al.  Consistent N-myc copy number in simultaneous or consecutive neuroblastoma samples from sixty individual patients. , 1987, Cancer research.

[19]  A. Nakagawara,et al.  Amplification of N-myc oncogene in stage II and IVS neuroblastomas may be a prognostic indicator. , 1987, Journal of pediatric surgery.

[20]  G. Tonini,et al.  N‐myc Oncogene Amplification in a Patient with IV‐S Neuroblastoma , 1987, The American journal of pediatric hematology/oncology.

[21]  M. Schwab,et al.  Detection of N-myc oncogene expression in human neuroblastoma by in situ hybridization and blot analysis: relationship to clinical outcome. , 1986, Cancer research.

[22]  H. Sather,et al.  Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. , 1985, The New England journal of medicine.

[23]  M. Israel,et al.  Decreased expression of N-myc precedes retinoic acid-induced morphological differentiation of human neuroblastoma , 1985, Nature.

[24]  M Schwab,et al.  Enhanced expression of the human gene N-myc consequent to amplification of DNA may contribute to malignant progression of neuroblastoma. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[25]  H. B. Marsden,et al.  Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. , 1984, Journal of the National Cancer Institute.

[26]  H. Varmus,et al.  Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. , 1984, Science.

[27]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[28]  A. Feinberg,et al.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. , 1983, Analytical biochemistry.

[29]  A. Evans,et al.  A proposed staging for children with neuroblastoma. Children's cancer study group A , 1971, Cancer.

[30]  Galil-ogly Ga,et al.  Tumors of the sympathetic nervous system , 1962 .